TG Therapeutics | TGTX - Equity Capital And Reserves

Stock Price
30.36
Daily Change
0.32 1.07%
Monthly
2.81%
Yearly
-27.52%
Q1 Forecast
27.12

TG Therapeutics reported $648.02M in Equity Capital and Reserves for its fiscal quarter ending in December of 2025.





Equity Capital And Reserves Change Date
AbbVie USD -3.27B 628M Dec/2025
Alaunos Therapeutics USD 2.8M 858K Sep/2025
Amgen USD 8.66B 961M Dec/2025
Ardelyx USD 166.95M 12.67M Dec/2025
Arrowhead Research USD 568.42M 102.37M Dec/2025
Bayer EUR 25.95B 3.75B Dec/2025
Biogen USD 18.21B 573.5M Sep/2025
Corcept Therapeutics USD 647.8M 15.9M Dec/2025
Curis USD -13.99M 7.38M Jun/2025
Gilead Sciences USD 22.62B 1.16B Dec/2025
Infinity Pharmaceuticals USD -37.41M 9.08M Jun/2023
J&J USD 78.47B 0 Sep/2025
Karyopharm Therapeutics USD -269.26M 30.33M Sep/2025
Novartis USD 46.13B 1.38B Dec/2025
Novavax USD -127.75M 28.92M Dec/2025
PTC Therapeutics USD -205.31M 49.56M Dec/2025
Puma Biotechnology USD 115.27M 10.55M Sep/2025
Regeneron Pharmaceuticals USD 31.26B 299.1M Dec/2025
Roche Holding CHF 33.8B 758M Dec/2025
TG Therapeutics USD 648.02M 40.8M Dec/2025
Verastem USD -15.53M 16.91M Sep/2025
Vertex Pharmaceuticals USD 18.67B 1.35B Dec/2025